Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $7.4 Million Public Offering of Medical Transcript Billing, Corp.
Press Release – New York, NY – June 23, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcription Billing, Corp. (MTBC.NASDAQ). MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions.
MTBC received approximately $7.4 million in gross proceeds from the sale of 294,698 shares of Series A Preferred Stock sold to the public at a price of $25 per share for an aggregate offering amount of $7,367,450. The series A Preferred Stock is traded on NASDAQ under the symbol “MTBCA.” The offering is expected to close on or around June 28, 2017, subject to the satisfaction of customary closing conditions.
The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia, Tom Rose and Associate Jay Yamamoto.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Founding Partner Marc Ross Speaks at Benzinga Cannabis Capital Conference - August 15, 2018
- Founding Partner Gregory Sichenzia Featured in the Media Discussing Scrutiny of Elon Musk’s Twitter Communications - August 15, 2018
- Founding Partner Gregory Sichenzia Featured on Business Insider Discussing Elon Musk’s Tweets and Securities Legality - August 8, 2018